Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by kevinNashon Aug 13, 2019 10:49am
90 Views
Post# 30021843

RE:RE:RE:RE:Do they have money to complete Ryplazim????

RE:RE:RE:RE:Do they have money to complete Ryplazim????Who will fund them is the question of the day.  Can you imagine that scenario?  "Hi, we just wiped out millions of investors and now we are looking for more investors, Are you interested?"   



biotech1973 wrote:
Who will fund them this time. Thats another question. Looking at the way things are, partnership is another big challenge. A TSX stock from 3.60$ to not even 1 cent now in just 2 years. Moreover, a slide to 3$ in so much in the cards now. shorts have another year to blow this one. 1Half of 2020 is another year and i am 100% confident that 2H will be announced in next quarter. So tecnically the thing which should have been approved with no delay considering FDA agrred on checkpoint amendments, these bunch of jokers were busy restructuring it rather than focusing on source of income. They need a good management person at the top,not these clowns who knows nothing about buisness


Bullboard Posts